Key Takeaways
- Revenue degrew 20% YoY as a large India defence ramp-down and Israel geopolitical headwinds hit both quantum and predictability, yet EBITDA margin expanded 192 bps YoY on a favourable revenue mix.
- Order intake surged to book-to-bill 1.6 at nearly ₹500 crores, driven by build-to-spec wins from two customers, new logo additions in eVTOL and EV charging, and a completely refreshed BEL order book carrying better margins.
- Profit after tax doubled YoY to ₹32.1 crores, but the jump includes a one-time Altek earnout reversal booked as other income; normalized PAT margin sat at 4%.
- The Altek acquisition is intact and performing, though its earnout was reversed because performance conditions were not met; US synergies are expected in year two.
- What to watch next quarter: Whether the promised Q4 FY26 YoY growth revival materializes, the pace of order book execution from the ₹2,300 crore backlog, and conversion of advanced-stage customer discussions into key accounts.
Revenue Headwinds & Mix Shift
- India defence ramp-down drove a 40% standalone business decline, tied entirely to one large customer whose orders from the Indian Ministry of Defence have not yet materialized; the company is still working with that customer and expects orders to return once the MoD releases them.
- Israel geopolitical impact slowed decision-making and reduced both revenue quantum and predictability; management now expects stability to return to the region, which would support business recovery given Israel's importance as a market.
- Industry mix transformed from ~70% Aerospace & Defence to a more diversified portfolio: Aerospace 37%, Defence 8%, Industrial 30%, Medical 15%, driven by the Altek acquisition and deliberate growth in industrial and tech segments.
- Box build grew 34% YoY, a stickier and slightly higher-margin segment than traditional PCBA, contributing to the margin expansion story.
- Geography split now stands at 85% rest of world, 14% India after the domestic ramp-down, but India is expected to grow and remains a focus market with pipeline orders expected in Q3.
Krishna Bodanapu: "I think it is important to note that Israel is a key market for us and the geopolitical situation there has had a significant impact both in the quantum of revenue and predictability of revenue. Where credit is due and thanks to President Trump, we now can expect stability to return to the region which will also greatly support stability in our business given the importance of Israel as a market to us."
Order Book & New Wins
- Order intake of nearly ₹500 crores delivered a book-to-bill of 1.6, with management guiding to a full-year book-to-bill of 1.4 to 1.5; the order book composition mirrors the current revenue mix, with 20% coming from build-to-spec orders.
- Japanese eVTOL win is a build-to-spec project currently in the design phase; mass production is expected after 2.5 to 3 years and will run for a 9-year period, with the first manufacturing orders likely from FY28 onwards.
- Indian EV charging win came from a company backed by a global giant, with a short sales cycle; management expects it to become a multi-million-dollar opportunity.
- BEL order book completely refreshed with much better margin revenue, giving management confidence in sustaining double-digit EBITDA margins going forward.
- Advanced discussions are underway with several promising companies, with some expected to convert into key accounts over the next one or two quarters.
- BTS differentiation rests on a design capability that management calls unique to Cyient DLM; almost all BTS orders will eventually enter mass production, though the bulk of manufacturing orders will come from FY28 onward, with smaller ones continuing through FY27.
Shrinivas Kulkarni: "Design capability is very unique to Cyient DLM. I don't think anybody can boast of having such a large design setup to service our clients."
Margins & Profitability
- EBITDA margin expanded 192 bps YoY and over 100 bps sequentially despite revenue degrowth, because the quality of revenue from a favourable mix more than offset under-absorption from volume loss; the exit of one large low-margin customer improved the overall mix.
- PAT grew 108% YoY to ₹32.1 crores, but this includes a one-time reversal of the Altek earnout booked as other income because performance conditions were not met; the normalized PAT margin was 4%.
- Margin profiles across industries are now quite comparable, so as business grows, margins are expected to expand further; the order backlog carries similar quality of revenue to the current quarter.
- Working capital improved with net working capital days dropping to 139 from 165, marking the fourth consecutive quarter of positive free cash flow; both DIO and DSO improved.
- Customer advances are being secured wherever longer inventory blockage is expected, and the company has been able to get advances from multiple clients, not just the defence customer.
Shrinivas Kulkarni: "Now, this margin growth is despite the loss of volume. So, that means even though we had under-absorption because of the volume loss, we have been able to get to a double-digit EBITDA margin because of the quality of revenue."
Altek Acquisition & US Operations
- Altek acquisition remains intact and is performing well, positioning the company for US growth; the earnout was reversed because performance conditions were not met, but the underlying business is doing fine.
- US synergies expected in year two, with quotes already submitted to existing customers from the Torrington unit and orders expected this quarter; the acquisition also helped diversify the industry mix away from Aerospace & Defence.
- M&A strategy is focused on enhancing client proximity, strengthening capabilities, and entering new industries such as rail and automotive, with active scouting for acquisitions in North America and Europe.
Rajendra Velagapudi: "Our M&A strategy is focused on enhancing client proximity, strengthening our capabilities and ascertaining entry into new industries such as rail and automotive. So, if you look at our strategy, what we just coined it as a set, which is strengthen, expand and transform."
Growth Outlook & Seasonality
- H2 revenue is expected to follow the typical 55-60% pattern, with growth reviving on a YoY basis starting from Q4 FY26; Q1 and Q2 have already seen good sequential growth, and that pace is expected to accelerate through the rest of the year.
- Growth is expected to come from the Industrial side, less from Defence in the near term; the company is consciously expanding its non-A&D customer base in Industrial and Automotive segments, with trends visible in Q3 and Q4.
- BTS revenues are expected to rise in FY27 vs FY26, though management declined to quantify the ramp by FY26-end, citing dependence on win rates and customer cycles; the bulk of BTS manufacturing orders will arrive from FY28 onward.
- Some contracts run into 20 years, providing stability that allows the company to aggressively grow the rest of the business.
- Land acquired in Mysore for building an owned factory, signalling capacity expansion to support future growth.
Krishna Bodanapu: "We have refreshed the BEL revenue, at least the order book is completely refreshed with a much better margin revenue, which gives us confidence that we will maintain the double-digit EBITDA margins at least or into the foreseeable future and really grow the double digits because this time we barely passed 10."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Book-to-bill ratio | 1.4 to 1.5 for the full year | FY26 |
| YoY revenue growth revival | Growth to resume starting Q4 | Q4 FY26 |
| EBITDA margin | Maintain double-digit margins, grow from current ~10% | Foreseeable future |
| BTS revenue growth | BTS revenues to increase vs FY26 | FY27 |
| Altek US synergies | Orders expected from Torrington unit | Current quarter (Q3 FY26) |
| New logo conversion | Some advanced discussions to convert into key accounts | Next 1-2 quarters |
| India pipeline orders | Orders expected from domestic pipeline | Q3 FY26 |
| BTS mass production (bulk) | Majority of manufacturing orders to begin | FY28 onwards |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue | ₹310.6 cr, -20% YoY |
| Order intake | ~₹500 cr, book-to-bill ratio of 1.6 |
| H1 cumulative order intake | >₹1,000 cr, +130% YoY |
| Order backlog | ₹2,291 cr, net addition of ₹159.3 cr |
| EBITDA | ₹31.2 cr |
| EBITDA margin | 10.0%+, +192 bps YoY and +100 bps QoQ |
| Reported profit | ₹32.1 cr, +108% YoY; includes one-time earnout reversal gain |
| Normalized PAT margin | 4%, +8% YoY |
| Reported profit margin | 10.3%, elevated due to one-time item |
| Net working capital | 139 days, improved from 165 days |
| Operational free cash flow | ₹46 cr; reported FCF ₹27 cr after Mysore land acquisition |
| Industry mix | Aerospace 37%, Defence 8%, Industrial 30%, Medical 15% |
| Box build growth | ~34% YoY |
| Geography mix | 85% rest of world, 14% India |
| Effective tax rate | 25.8%, excluding extraordinary gains |
| Build-to-spec share of order book | >10% |
| US business share | ~40% of revenue expected for FY26 |
| Expected full-year book-to-bill | 1.4 to 1.5 |